New York Cannabis Control Board Holds 1st Meeting, Medical Homegrow Delayed

New York Cannabis Control Board NYC MRTA, homegrow legalization discussed

The New York Cannabis Control Board (CCB) met for the first time this week and began implementing legalization. However, medical homegrow implementation is delayed.

NYC National Organization for the Reform of Marijuana Laws (NORML) Executive Director Ryan Lepore noted that the CCB appointments were delayed. So regulations regarding medical homegrow were also delayed.

He said they’re “kind of in a tough place playing catch up.”

The issue was the CCB officials had to be approved by the legislature. New York’s legislature did not do so by the time it adjourned for the year at the end of June.

Cannabis legalization was signed into law by former Governor Andrew Cuomo in the spring. But he did not move forward on implementation before resigning in disgrace this summer. New York’s new Governor, Kathy Hochul, has been eager to make a clean break with the past. Thus, she called the New York legislature back into session and urged them to approve the appointments of CCB officials.

Lepore noted the regulations would determine the details of medical homegrow. He said that a patient registry for recommendations would likely house a medical homegrow registration as well.

They still must decide whether or not give to allow any patient to homegrow or create qualifications.

“There’s a lot of things and questions that still have to be answered,” Lepore said.

He said there’s also a question of how much one could homegrow.

“Every moment we have wasted has resulted in the furtherance of a public health issue,” Lepore added.

New York Cannabis Control Board Down to Business

The Board appointed Jason Starr as the Chief Equity Officer and the Office of Cannabis Management (OCM) senior staff. The CCB will oversee the OCM.

As Chief Equity Officer, Starr is supposed to establish a “robust social and economic equity program to prioritize the licensing of members of communities disproportionally impacted by the War on Drugs.

It will pave the way for their participation in the new cannabis industry.

“Mr. Starr … has the knowledge and expertise needed to ensure equity and justice are infused in the fabric of this new agency,” said Board Chair Tremaine Wright. “We are moving full speed ahead with establishing an inclusive cannabis industry that operates safely and promotes public health. And repairs the harms of the past.”

Starr worked as the Director of the Long Island Chapter of the NY Civil Liberties Union and served as an Assistant Counsel for Civil Rights under Cuomo, where he spearheaded the 2019 cannabis decriminalization bill.

“They made good appointments in for the most part,” Lepore said. “They still have a lot of things … that need to be addressed.”

The Board expanded the types of clinical providers who certify medical cannabis patients to any practitioner licensed to prescribe controlled substances in New York, including dentists, podiatrists, and midwives.

The New Jersey Cannabis Regulatory Commission has yet to enact a similar provision from the Jake Honig Act of 2019.

Medical Cannabis Changes

The CCB increased the amount of approved medical cannabis that can be dispensed to a certified patient or designated caregiver from a 30-day supply to a 60-day supply. They also waived the $50 patient and caregiver registration fee.

Furthermore, they streamlined approval for hospitals, residential facilities, and schools to become designated caregiver facilities. They could hold and dispense products for patients.

“These changes will assist certified patients and designated caregivers to acquire and administer approved medical cannabis products. They represent the first of many changes to come for the State’s medical cannabis program. As a result of the passage of the MRTA (legalization bill),” Wright said.

The OCM has released guidance allowing existing dispensaries to sell whole flower to patients as soon as the State’s testing approves those products. Previously, only ground flower was available.

“Sale of whole flower is an important step toward patient access. And affordability of medical cannabis,” said Assembly Health Committee Chair and Compassionate Care Act Sponsor Richard Gottfried (D).

Lepore said the “energy in the Board was pretty good.”

He called it a “stark difference from what we were experiencing previously.”

He said there was a great deal of wariness that the appointments would be puppets of former Governor Cuomo, who many cannabis advocates believe was not in favor of a social-equity-centric approach to legalization.

CCB Appointees

Before the CCB met, the New York State Senate approved Hochul’s appointment of Tremaine Wright as Chair of the New York Cannabis Control Board (CCB). Christopher Alexander was made Executive Director of the Office of Cannabis Management (OCM). Hochul also appointed Reuben McDaniel, III, and Jessica Garcia to the Board. The legislature appointed Adam Perry and Jen Metzger to the Board.

“One of my top priorities is to finally get New York’s cannabis industry up and running. This has been long overdue,” Hochul said. “They will do a tremendous job of outlining and implementing regulations that are safe, fair, and transparent and that recognize the need to remedy the impact that prohibition has had on communities of color.”

Tremaine Wright was previously the first Director of the Department of Financial Services (DFS) Office of Financial Inclusion and Empowerment. She is also a former member Assemblywoman from Brooklyn.

Professional Background

Chris Alexander works as the Government Relations and Policy Manager for Village, the largest black Multi-State Operator (MSO) cannabis corporation. He previously was a Policy Coordinator for the Drug Policy Alliance (DPA), a leader in the fight for cannabis legalization.

Alexander was the architect of the cannabis legalization campaign and lead drafter of the adult-use legalization bill in New York.

Lepore said Alexander was an amazing appointment as OCM Executive Director. He worked on the bill directly and advised the State Senate Democrats.

Reuben R. McDaniel III was the President and CEO of the Dormitory Authority of the State of New York (DASNY). McDaniel founded an investment advisory firm. He managed more than $50 million in investment portfolios and business assets for various professionals.

Jessica García was Assistant to the President of the Retail, Wholesale Department Store Union (RWDSU), UFCW. They’re a national labor union representing workers along the food supply chain and some in non-food retail and healthcare.

Adam Perry was selected for the New York Cannabis Control Board by Assembly Speaker Carl Heastie (D). He was a lawyer in private practice.

Former State Senator Jen Metzger, a Democrat, was appointed to the Board by Senate Majority Leader Andrea Stewart-Cousins (D).

“I’m cautiously optimistic,” Lepore said. He noted they “need all the help they can get.”

Newsletter

Subscribe to The Heady Chronicle!

Please wait...

Thank you for signing up!